³» ¿ë |
We"d like to offer you the job http://thisav.fun/ thisav Regeneron had won FDA approval for a new drug, Eylea, to treat a leading cause of blindness in the elderly. Sales were expected to take offâ?”as long as the firm"s manufacturing facilities continued to meet FDA standards. Millennium owned 10,000 shares of Regeneron at the end of 2011. |